Desloge R B, Finstad C L, Sassoon J, Han J C, Parisier S C, Albino A P
Department of Otolaryngology-Head and Neck Surgery, Manhattan Eye, Ear, and Throat Hospital, New York, NY 10021, USA.
Otolaryngol Head Neck Surg. 1997 Jan;116(1):58-63. doi: 10.1016/S0194-59989760352-6.
Cholesteatoma is a destructive process involving an accumulation of desquamated keratin arising from squamous epithelium that pathologically has invaded the middle ear or mastoid process. The clinical hallmarks of cholesteatomas, namely invasion of healthy tissues, migration, unrestrained proliferation, aggressiveness, recidivism, and uncoordinated differentiation predict the existence of defects in the normal biology and biochemistry of the cellular constituents that compose a cholesteatoma, as well as in the cellular interactions between these cells, the surrounding normal tissue, and the host. In the current report, we analyzed 11 cholesteatomas and matched healthy tissue for altered expression in four different cell surface peptidases, aminopeptidase A, aminopeptidase N, dipeptidyl peptidase IV, and neutral endopeptidase. We suggest that peptidases may modulate cell growth and differentiation by inactivating stimulatory signals (or conversely, by activating inhibitory signals).
